Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX with or without Surgery for Metastatic Colon Cancer
NCT02291744Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Oct 2014
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Fudan University. Primary endpoint: Time to Failure of Strategy. Status: unknown.
Beyond the preview
Go deeper on NCT02291744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291744.